A Phase II Study to Assess the Ability of Neoadjuvant Chemotherapy +/- Second Look Surgery to Eliminate All Measurable Disease Prior to Radiotherapy for NGGCT
ACNS0232
A Phase III Group-Wide Study
STUDY CHAIR: Jeffrey C. Allen, M.D.
ACNS0232
A Phase III Group-Wide Study
STUDY CHAIR: Jeffrey C. Allen, M.D.
Prof Richard G Grundy, MBChB, Sophie A Wilne, MBBS, Claire L Weston, MSc, Kath Robinson, BA, Linda S Lashford, MBBS, Prof James Ironside,
Amar Gajjar et al., Lancet Oncol 2006; 7: 813–20
Amendment 2.0, September 8, 2005, Resubmitted May 31, 2006
ARET0332
A Groupwide Phase III Study
STUDY CHAIR: Murali Chintagumpala, M.D.
ARET0331
A Phase III Limited Institution Study
STUDY CHAIR: Debra L. Friedman
Marcus K.J., Goumnerova L., Billett A.L., Lavally B., Scott R.M., Bishop K., Xu R., (...), Tarbell N.J.
(2005) International Journal of Radiation Oncology Biology Physics, 61
CHILDREN’S ONCOLOGY GROUP
A9952
A Phase III Intergroup COG Study
Final Version July 2004
נותנות החסות לאיגוד:
